Z-0341-2023 Class II Terminated

Recalled by Cytocell Ltd. — Cambridge

FDA device recall Z-0341-2023 was initiated by Cytocell Ltd. on October 27, 2022 and is designated Class II. Reason for recall: An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong coordinates… The recall status is terminated (terminated December 27, 2024). Affected quantity: 3 units.

Recall Details

Product Type
Devices
Report Date
December 7, 2022
Initiation Date
October 27, 2022
Termination Date
December 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 units

Product Description

CytoCell BCL11B Distal in Texas Red Spectrum- Analyte Specific Reagent Ref: MPD39782

Reason for Recall

An error with the chromomap on version 1 of the package insert which is incorrect. The nucleotide locations specified in the insert are correct but the map has been created using the wrong coordinates.

Distribution Pattern

TX

Code Information

Lot Number: RD22/230/11